Cost & insurance review · Updated July 2026
How much does Wegovy cost?
Medically reviewed by Editorial Medical Review, MD, NAMS-CMP
Quick answer
$0-$1,349/mo. Wegovy lists at $1,349/month in 2026 — the highest of the FDA-approved weight-loss GLP-1 drugs. NovoCare Self Pay offers cash-paying patients $499/month (4-dose pack). Commercial insurance with prior authorization plus the Wegovy Savings Offer reduces cost to as low as $0/month for eligible patients. Medicare Part D excludes Wegovy under the anti-obesity statutory carve-out.
Price ranges by tier
What each pricing tier includes, sourced from manufacturer pricing pages, Cost Plus Drugs, KFF, LillyDirect, and NovoCare.
Commercial insurance + Savings Offer
$0-$200/mo- Prior authorization required
- Commercial plan must cover Wegovy
- Savings cap applies annually
- Excludes Medicare/Medicaid
NovoCare Self Pay (cash)
$499/mo- 4-dose single-dose pen pack
- Any approved dose (0.25-2.4 mg)
- Available to patients paying out of pocket
Retail pharmacy (list price)
$1,349/mo- 4-pen auto-injector pack
- No insurance, no savings card
Medicare Part D
Not covered- Anti-obesity exclusion applies statutorily
Factors that affect cost
- Plan formulary status and prior-authorization criteria
- Dose (all doses $499/mo via NovoCare Self Pay)
- Insurance status (commercial vs Medicare vs uninsured)
- State Medicaid formulary (CA, MD, MA, MI, NY, VA cover; TX, FL, GA, NC exclude)
Insurance context
Major commercial insurers (BCBS, Aetna, Cigna, UnitedHealthcare) increasingly cover Wegovy with prior authorization requiring BMI ≥30 or ≥27 + weight-related comorbidity. Medicare Part D excludes anti-obesity drugs from coverage as of 2026 — a statutory exclusion. Medicaid coverage varies dramatically by state.
Financial help options
- Wegovy Savings Offer ↗: Reduces commercially-insured cost to $0-$200/month for eligible patients. Excludes Medicare/Medicaid.
- NovoCare Self Pay ↗: $499/mo cash-pay direct-to-patient program. Any dose.
- Novo Nordisk patient assistance: Free Wegovy for qualifying uninsured low-income patients.
- HSA/FSA accounts: Cover GLP-1 prescriptions and telehealth visits with itemized receipts.
Related brands
Editorial cross-links only — no affiliate CTAs. Follow each link for our full brand review, formulary, and clinician model.
Related questions
Frequently asked questions
- How does NovoCare Self Pay compare to the Wegovy Savings Offer?
- NovoCare Self Pay ($499/month) is for cash-paying patients without insurance coverage. The Wegovy Savings Offer ($0-$200/month) is for commercially-insured patients whose plan covers Wegovy. They are mutually exclusive.
- Is generic Wegovy available?
- No. Semaglutide patent protection extends through 2031-2033 in the US. Compounded semaglutide is legally restricted after FDA declared the shortage resolved in late 2024.
- Will Medicare cover Wegovy in 2026?
- Currently no. Medicare Part D excludes anti-obesity drugs by statute. CMS proposed a coverage rule in 2024 but it remains in comment period. Medicare beneficiaries can access Wegovy via NovoCare Self Pay ($499/month).
- Why is Wegovy more expensive than Ozempic if same molecule?
- List price reflects FDA indication and market positioning. Wegovy ($1,349) is priced for the weight-management market; Ozempic ($935) for the diabetes market. Wegovy uses higher doses (up to 2.4 mg/week), requiring more drug per pen.
Sources
Every pricing figure is sourced from public manufacturer pages, Cost Plus Drugs, KFF, or FDA data. External links open in a new tab.
Related cost questions
ClearHormones publishes editorial pricing research quarterly. Pricing may change without notice — always confirm current terms on the manufacturer or brand pricing page before purchasing.